Certification: | CE |
---|---|
Disinfection: | Disinfection |
Color: | Transparent |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
DESCRIPTION:
LANLUMA is a line of fillers based on poly-L-Lactic acid (PLLA) that stimulate collagen production and have
proven efficacy. Designed for the face and body.Quick to prepare.The stimulation of collagen production in patients
allows a beautiful natural look to the result.LANLUMA is quick to prepare,
its favorable safety profile and efficacy have been demonstrated.LANLUMA enables physicians to meet the expectations of
their patients.SINCLAIR is committed to anticipating and responding to your and their needs.RESULTSLANLUMA results
appear gradually over a period of two to three months, as the natural collagen forms before stabilizing.In most cases,
treatment will only require a reduced downtime.Results last up to two years.
COMPOSITION
Constitution of LANLUMA VET X:
40.4% Poly-L-lactic acid (PLLA)
25.4% Sodium carboxymethyl cellulose (CMC)
34.2% Mannitol
PRESENTATION
LANLUMA is available in two packagings:
1/ LANLUMA V:
210 mg vialPLLA 210 mg /BOTTLESuitable for corrections of areas such as the face or neck.To be diluted with 15mL of sterile water.Increase the volume of depressed areas, in particular to correct skin depressions.
USE LANLUMA V: TEMPS. FACE CHEEKS. NASO-GENIUS WRINKLES. CHIN. MANDIBULAR LINES. SCARS. NECK AND DECOLLETE.
DO NOT USE LANLUMA V in: the perioral region. The nose. The front region. The furrow of the eyelids. Temporal region. In the nasogenian furrow parallel to the furrow.
Deep or subcutaneous injection.
Duration: 2 years.
2/ LANLUMA X:
630 mg vialPLLA 630 mg/BOTTLESuitable for treating areas of the body such as the buttocks.
To be diluted with 40 mL of sterile water.
Increase the volume of depressed areas, in particular to correct skin depressions.
USE LANLUMA X: TO OPTIMIZE THE CURVES AND CONTOURS OF THE BODY. SHAPE AND VOLUME OF THE BUTTOCKS. FIRMNESS AND TEXTURE OF THE SKIN. NARMS. THIGHS.
Deep or subcutaneous injection.
Duration: 2 years.